Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation

AP-1 as a regulator of cell life and death

Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · see citing works

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761 · see citing works

AP-1 in cell proliferation and survival

Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,733 · see citing works

Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity

Chinenov, Y. V., & Kerppola, T. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204385 · Cited by 715 · see citing works

Control of cell cycle progression by c-Jun is p53 dependentPreprint

Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Möhle-Steinlein, U., Tian, J., Karin, M., Angel, P., & Wagner, E. F. (1999) · Genes & Development · doi:10.1101/gad.13.5.607 · Cited by 576 · see citing works

The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation

Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494 · see citing works

jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun

Schütte, J., Viallet, J., Nau, M. M., Segal, S., FEDORKO, J., & Minna, J. D. (1989) · Cell · doi:10.1016/0092-8674(89)90755-1 · Cited by 482 · see citing works

The requirement for eukaryotic initiation factor 4A (eIF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure

Svitkin, Y. V., Pause, A., Haghighat, A., Pyronnet, S., Witherell, G. W., Belsham, G. J., & Sonenberg, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477 · see citing works

Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.

Holt, J. T., Gopal, T. V., Moulton, A. D., & Nienhuis, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4794 · Cited by 439 · see citing works

The jun and fos protein families are both required for cell cycle progression in fibroblasts.

Kovary, K., & Bravo, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4466 · Cited by 436 · see citing works

Function and regulation of AP-1 subunits in skin physiology and pathology

Angel, P. E., Szabowski, A., & Schorpp‐Kistner, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204380 · Cited by 409 · see citing works

Dominant negative mutants of mammalian translation initiation factor eIF‐4A define a critical role for eIF‐4F in cap‐dependent and cap‐independent initiation of translation.

Pause, A., Méthot, N., Svitkin, Y. V., Merrick, W. C., & Sonenberg, N. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06370.x · Cited by 393 · see citing works

Tumour promoter induces anchorage independence irreversibly

Colburn, N. H., Former, B. F., Nelson, K. A., & Yuspa, S. H. (1979) · Nature · doi:10.1038/281589a0 · Cited by 284 · see citing works

eIF4A: The godfather of the DEAD box helicases

Rogers, G. W., Komar, A. A., & Merrick, W. C. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72073-4 · Cited by 274 · see citing works

Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis

Hsu, T.-C., Young, M. R., Cmarik, J. L., & Colburn, N. H. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00220-3 · Cited by 265 · see citing works

Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.

Schütte, J., Minna, J. D., & Birrer, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2257 · Cited by 254 · see citing works

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation

Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254 · see citing works

Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death

Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223 · see citing works

cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype

Smith, L. M., Wise, S., Hendricks, D. T., Sabichi, A. L., Bos, T. J., Reddy, P., Brown, P. H., & Birrer, M. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202989 · Cited by 214 · see citing works

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation

Yang, H.-S., Jansen, A. P., Nair, R., Shibahara, K., Verma, A. K., Cmarik, J. L., & Colburn, N. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204137 · Cited by 185 · see citing works

Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion.

Colburn, N. H., Wendel, E. J., & Abruzzo, G. K. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6912 · Cited by 185 · see citing works

Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays

Chauhan, D., Auclair, D., Robinson, E. K., Hideshima, T., Li, G., Podar, K., Gupta, D., Richardson, P. G. G., Schlossman, R. L., Krett, N. L., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205205 · Cited by 165 · see citing works

Transactivation of Fra-1 and Consequent Activation of AP-1 Occur Extracellular Signal-Regulated Kinase Dependently

Young, M. R., Nair, R. R., Bucheimer, N. R., Tulsian, P., Brown, N., Chapp, C., Hsu, T.-C., & Colburn, N. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.587-598.2002 · Cited by 130 · see citing works

Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth

Liu, Y., Ludes-Meyers, J. H., Zhang, Y., Munoz‐Medellin, D., Kim, H.-T., Lü, C., Ge, G., Schiff, R., Hilsenbeck, S. G., Osborne, C. K., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205883 · Cited by 128 · see citing works

Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes

Li, J. J., Rhim, J. S., Schlegel, R., Vousden, K. H., & Colburn, N. H. (1998) · Oncogene · doi:10.1038/sj.onc.1201798 · Cited by 126 · see citing works

Transcriptional regulation of cell invasion

Ozanne, B. W., McGarry, L., Spence, H. J., Johnston, I., Winnie, J. N., Meagher, L., & Stapleton, G. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00175-1 · Cited by 123 · see citing works

Differential Transcriptional Regulation of <i>CD161</i> and a Novel Gene, <i>197/15a</i> , by IL-2, IL-15, and IL-12 in NK and T Cells

Azzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P., & Perussia, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3493 · Cited by 105 · see citing works

Analysis of AP-1 function in cellular transformation pathways

Suzuki, T., Murakami, M., Onai, N., Fukuda, E., Hashimoto, Y., Sonobe, M. H., Kameda, T., Ichinose, M., Miki, K., & Iba, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.3527-3535.1994 · Cited by 100 · see citing works

Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor

Zhang, Z., & DuBois, R. N. (2001) · Oncogene · doi:10.1038/sj.onc.1204588 · Cited by 90 · see citing works

Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors

Dong, Z., Lavrovsky, V. A., & Colburn, N. H. (1995) · Carcinogenesis · doi:10.1093/carcin/16.4.749 · Cited by 82 · see citing works

The Jun and Fos Protein Families Are Both Required for Cell Cycle Progression in Fibroblasts

Kovary, K., & Bravo, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4466-4472.1991 · Cited by 77 · see citing works

Antisense RNA of Proto-Oncogene c-fos Blocks Renewed Growth of Quiescent 3T3 Cells

Nishikura, K., & Murray, J. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.639-649.1987 · Cited by 71 · see citing works

Role of multidrug-resistance protein 2 in glutathioneS-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells

Morrow, C. S., Smitherman, P. K., & Townsend, A. J. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200011)29:3 · Cited by 65 · see citing works

Molecular Cloning of the Genes Suppressed in RVC Lymphoma Cells by Topoisomerase Inhibitors

Onishi, Y., & Kizaki, H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1609 · Cited by 34 · see citing works

c‐jun and multistage carcinogenesis: Association of overexpression of introduced c‐jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter‐induced transformation

Watts, R. G., Ben‐Ari, E. T., Bernstein, L. R., Birrer, M. J., Winterstein, D., Wendel, E. J., & Colburn, N. H. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130106 · Cited by 32 · see citing works

AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers

Suzukawa, K., & Colburn, N. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205281 · Cited by 27 · see citing works

Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding and JunD expression and form different AP-1–DNA complexes than promotion sensitive cells

Bernstein, L. R., & Walker, S. E. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00191-8 · Cited by 21 · see citing works

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882 · see citing works

MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4

Cheng, Y., Liu, X., Zhang, S., Lin, Y., Yang, J., & Zhang, C. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.008 · Cited by 368 · see citing works

Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression to Suppress Colon Carcinoma Cell Invasion

Yang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1297-1306.2006 · Cited by 202 · see citing works

Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors

Leupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210234 · Cited by 163 · see citing works

Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis

Afonja, O., Juste, D., Das, S., Matsuhashi, S., & Samuels, H. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207983 · Cited by 154 · see citing works

Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion

Schmid, T., Jansen, A. P., Baker, A. R., Hegamyer, G., Hagan, J. P., & Colburn, N. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1719 · Cited by 151 · see citing works

Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein

Palamarchuk, A., Efanov, A., Maximov, V., Aqeilan, R. I., Croce, C. M., & Pekarsky, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3469 · Cited by 151 · see citing works

Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun

Bitomsky, N., Böhm, M., & Klempnauer, K.-H. (2004) · Oncogene · doi:10.1038/sj.onc.1208064 · Cited by 134 · see citing works

Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity

Jansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132 · see citing works

Crystal structure of the eIF4A–PDCD4 complex

Chang, J. H., Cho, Y. H., Sohn, S. Y., Choi, J. M., Kim, A., Kim, Y. C., Jang, S. K., & Cho, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808275106 · Cited by 120 · see citing works

The role of Pdcd4 in tumour suppression and protein translation

Wang, Q., & Yang, H. (2018) · Biology of the Cell · doi:10.1111/boc.201800014 · Cited by 113 · see citing works

Tumor Suppressor PDCD4 Represses Internal Ribosome Entry Site-Mediated Translation of Antiapoptotic Proteins and Is Regulated by S6 Kinase 2

Liwak, U., Thakor, N., Jordan, L. E., Roy, R., Lewis, S. M., Pardo, O. E., Seckl, M., & Holcik, M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06317-11 · Cited by 106 · see citing works

Frequent loss of PDCD4 expression in human glioma: Possible role in the tumorigenesis of glioma

Gao, F., Zhang, P., Zhou, C., Li, J., Wang, Q., Zhu, F., Ma, C., Sun, W., & Zhang, L. (2007) · Oncology Reports · doi:10.3892/or.17.1.123 · Cited by 100 · see citing works

Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA

Wedeken, L., Singh, P., & Klempnauer, K.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269456 · Cited by 75 · see citing works

Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice

Hwang, S.-K., Jin, H., Kwon, J. T., Chang, S.-H., Kim, T. H., Cho, C.-S., Lee, K. H., Young, M. R., Colburn, N. H., Beck, G. R., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302983 · Cited by 44 · see citing works

A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: Inhibition of translation elongation

Biyanee, A., Ohnheiser, J., Singh, P., & Klempnauer, K.-H. (2015) · Oncogene · doi:10.1038/onc.2014.83 · Cited by 37 · see citing works

An evolutionarily conserved interaction of tumor suppressor protein Pdcd4 with the poly(A)-binding protein contributes to translation suppression by Pdcd4

Fehler, O., Singh, P., Haas, A., Ulrich, D., Müller, J. P., Ohnheiser, J., & Klempnauer, K.-H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku800 · Cited by 35 · see citing works

Tumor suppressor protein Pdcd4 interacts with Daxx and modulates the stability of Daxx and the Hipk2-dependent phosphorylation of p53 at serine 46

Kumar, N., Wethkamp, N., Waters, L. C., Carr, M. D., & Klempnauer, K.-H. (2013) · Oncogenesis · doi:10.1038/oncsis.2012.37 · Cited by 30 · see citing works

Promoter cloning and characterization of the human programmed cell death protein 4 (<i>pdcd4</i>) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators

Leupold, J. H., Asangani, I. A., Mudduluru, G., & Allgayer, H. (2012) · Bioscience Reports · doi:10.1042/bsr20110045 · Cited by 23 · see citing works

Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms

Nakashima, M., Hamajima, H., Xia, J., Iwane, S., Kwaguchi, Y., Eguchi, Y., Mizuta, T., Fujimoto, K., Ozaki, I., & Matsuhashi, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.05.002 · Cited by 17 · see citing works

Diaryl Disulfides as Novel Stabilizers of Tumor Suppressor Pdcd4

Schmid, T., Blees, J. S., Bajer, M. M., Wild, J., Pescatori, L., Cuzzucoli Crucitti, G., Scipione, L., Costi, R., Henrich, C. J., Brüne, B., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151643 · Cited by 10 · see citing works

PDCD4 triggers α-synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson’s disease

Cao, B., Chen, X., Li, Y., Zhou, T., Chen, N., Guo, Y., Zhao, M., Guo, C., Shi, Y., Wang, Q., et al. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00760-9 · Cited by 8 · see citing works

Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells.

Wang, H., Xie, Z., & Scott, R. E. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.4.1151 · Cited by 35 · see citing works

Adipocyte differentiation selectively represses the serum inducibility of c-jun and junB by reversible transcription-dependent mechanisms.

Wang, H., & Scott, R. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4649 · Cited by 25 · see citing works

NF‐κB elements contribute to junB inducibility by lipopolysaccharide in the murine macrophage cell line RAW264.7

Frazier-Jessen, M. R., Thompson, C. D., Brown, R., Rawat, R., Nordan, R. P., & Feldman, G. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02295-0 · Cited by 23 · see citing works

Interactions among LRF-1, JunB, c-Jun, and c-Fos Define a Regulatory Program in the G 1 Phase of Liver Regeneration

Hsu, J., Bravo, R., & Taub, R. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4654-4665.1992 · Cited by 4 · see citing works

A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors

Daelemans, D., Clercq, E. D., & Vandamme, A. (2001) · Journal of Virological Methods · doi:10.1016/s0166-0934(01)00330-5 · Cited by 27 · see citing works